Skip to main content
SpringerLink
Log in

Methotrexat

Methotrexate

  • Leitthema: Meilensteine in der Rheumatologie: 75 Bände Innovation
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Seeger DR, Smith JM Jr, Hultquist ME (1947) Antagonist for pteroyl-glutamic acid. J Am Chem Soc 69(10):2567

    Article  CAS  PubMed  Google Scholar 

  2. Farber S, Diamond LK, Mercer RD, Sylvester RF, Wolff JA (1948) Temporary remissions in acute leucemia in children produced by folic acid antagonist, 4‑amino-pteroyl-glutamic acid (aminopterin). N Engl J Med 238:787–793

    Article  CAS  PubMed  Google Scholar 

  3. Gubner R, August S, Ginsberg V (1951) Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis. Am J Med Sci 221:176–182

    CAS  PubMed  Google Scholar 

  4. Rees RB, Bennett JH, Bostick WL (1955) Aminopterin for psoriasis. Arch Dermatol 72:133–143

    Article  CAS  Google Scholar 

  5. Gross D, Enderlin M, Fehr K (1967) Die immunsuppressive Behandlung der progredient chronischen Polyarthritis mit Antimetabolica und Cytostatika. Schweiz Med Wochenschr 97:1301

    CAS  PubMed  Google Scholar 

  6. Hoffmeister RT (1972) Methotrexate in rheumatoid arthritis (abstract). Arthritis Rheum 15:114

    Google Scholar 

  7. Wilke WS, Calabrese LH, Scherbel AL (1980) Methotrexate in the treatment of rheumatoid arthritis. Pilot study. Cleve Clin Q 47:305–309

    Article  CAS  PubMed  Google Scholar 

  8. Willkens RF et al (1980) Low-dose pulse methotrexate in rheumatoid arthritis. J Rheumatol 7:501–505

    CAS  PubMed  Google Scholar 

  9. Karger T, Rau R (1984) Methotrexat-Behandlung hochaktiver chronischer Polyarthritiden. Munch Med Wochenschr 126:560

    Google Scholar 

  10. Williams HJ et al (1985) Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 28:721–730

    Article  CAS  PubMed  Google Scholar 

  11. Weinblatt ME, Coblyn JS, Fox DA et al (1985) Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 312:818–822

    Article  CAS  PubMed  Google Scholar 

  12. Andersen PA, West SG, O’Dell JR et al (1985) Weekly pulse methotrexate in rheumatoid arthritis. Ann Intern Med 103:489–496

    Article  CAS  PubMed  Google Scholar 

  13. Thompson RN, Watts C, Edelman J, Russell AS (1984) A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. J Rheumatol 11:760–762

    CAS  PubMed  Google Scholar 

  14. Weinblatt ME, Kaplan H, Germain BF (1990) Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. Arthritis Rheum 33:330–338

    Article  CAS  PubMed  Google Scholar 

  15. Williams HJ, Ward JR, Reading JC et al (1992) Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. Arthritis Rheum 3:259–269

    Article  Google Scholar 

  16. Hamdy H, McKendry RJR, Mierins E, Liver JA (1987) Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. Arthritis Rheum 30:361–368

    Article  CAS  PubMed  Google Scholar 

  17. Jeurissen MEC, Boerbooms AMT, Putte LB van de et al (1991) Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight-week randomized, double blind trial. Arthritis Rheum 34:951–960

    Article  Google Scholar 

  18. Morrasut T, Goldstein R, Cyr M et al (1989) Goldsodiumthiomalat compared to low-dose methotrexate in the treatment of rheumatoid arthritis – a randomised double-blind 26-week trial. J Rheumatol 16:302–306

    Google Scholar 

  19. Suarez-Almazor ME, Fitzgerald A, Grace M, Russell AS (1988) A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate. J Rheumatol 15:753–756

    CAS  PubMed  Google Scholar 

  20. Rau R, Herborn G, Karger T et al (1991) A double blind randomized parallel trial of intramuscular methotrexate and goldsodiumthiomalate in early erosive rheumatoid arthritis. J Rheumatol 18:328–333

    CAS  PubMed  Google Scholar 

  21. Sander O, Herborn G, Bock E, Rau R (1999) Prospective six year follow up of patients withdrawn from a randomized study comparing parenteral gold salt and methotrexate. Ann Rheum Dis 58:281–287

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Bartels GM, Wijbrandts CA, Nurmohamed MT, Stapel S, Lems WF, Aarden L et al (2007) Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis. Ann Rheum Dis 66(7):921–926

    Article  Google Scholar 

  23. Burmester GR, Kivitz AJ, Kupper H, Arulmani U, Florentinus S, Goss Sl et al (2015) Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomized CONCERTO trial. Ann Rheum Dis 74(6):1037–1044

    Article  PubMed  Google Scholar 

  24. Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH et al (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343:1594–1602

    Article  Google Scholar 

  25. Klareskog L, Heijde D van der, Jager JP de, Gough A, Kalden J et al (2004) TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) study investigators. Therapeutic effect of the combination of etanerceptand methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomized controlled trial. Lancet 363:75–81

    Article  Google Scholar 

  26. Emery P, Breedveld FC, Hall S et al (2008) Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomized, double blind, parallel treatment trial. Lancet 372:375–382

    Article  CAS  PubMed  Google Scholar 

  27. Emery P, Breedveld FC, Heijde D van der et al (2010) Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis. Arthritis Rheum 62:674–682

    Article  CAS  PubMed  Google Scholar 

  28. Breedveld FC, Weisman M, Kavanaugh A, Cohen B et al (2006) The PREMIER study. A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 54:26–37

    Article  CAS  PubMed  Google Scholar 

  29. Emery P, Fleischmann RM, Moreland LW et al (2009) Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naïve patients with active rheumatoid arthritis. Arthritis Rheum 60:2272–2283

    Article  CAS  PubMed  Google Scholar 

  30. Emery P, Burmester GR, Bykerk VP et al (2015) Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomized, active-controlled AVERT study of 24 months, with a 12 month, double-blind treatment period. Ann Rheum Dis 74:19–26

    Article  CAS  PubMed  Google Scholar 

  31. Maini R, St Clair EW, Breedveld F et al (1999) Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. ATTRACT study group. Lancet 354:1932–1939

    Article  CAS  PubMed  Google Scholar 

  32. St Clair EW, Heijde DM van der, Smolen JS et al (2004) Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized controlled trial. Arthritis Rheum 50:3432–3443

    Article  CAS  PubMed  Google Scholar 

  33. Atsumi T, Yamamoto K, Takeuchi T et al (2016) The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C‑OPERA, shows inhibition of radiographic progression. Ann Rheum Dis 75:75–83

    Article  PubMed  Google Scholar 

  34. Edwards JCW, Szczepanski L, Szechinski J et al (2004) Efficacy of B‑cell targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350:2572–2581

    Article  CAS  PubMed  Google Scholar 

  35. Tak PP, Rigby WF, Rubbert-Roth A et al (2011) IMAGE Investigators. Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. Ann Rheum Dis 70:39–46

    Article  CAS  PubMed  Google Scholar 

  36. Smolen J, Landewe RB, Mease P et al (2009) Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomized controlled trial. Ann Rheum Dis 68:797–804

    Article  CAS  PubMed  Google Scholar 

  37. Burmester GR, Rigby WF, Vollenhoven RF van et al (2015) Tocilizumab in early progressive rheumatoid arthritis : FUNCTION, a randomised controlled trial. Ann Rheum Dis 75(6):1081 doi:10.1136/annrheumdis-2015-207628

    Article  PubMed  PubMed Central  Google Scholar 

  38. Rau R, Herborn G, Menninger H, Sangha O (1998) Progression in early erosive rheumatoid arthritis: 12 month results from a randomised controlled trial comparing methotrexate and gold sodium thiomalate. Br J Rheumatol 37:1220–1226

    Article  CAS  PubMed  Google Scholar 

  39. Rau R, Herborn G, Menninger H, Sangha O (2002) Radiographic outcome after three years of patients with early ersoive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one-year double-blind study in 174 patients. Rheumatology 41:196–204

    Article  CAS  PubMed  Google Scholar 

  40. Rau R, Herborn G, Karger T, Werdier D (1991) Retardation of radiologic progression in rheumatoid arthritis with methotrexate therapy: a controlled study. Arthritis Rheum 34:1236–1244

    Article  CAS  PubMed  Google Scholar 

  41. Reykdal S, Steinsson K, Sigurjonsson K, Brekkan A (1989) Methotrexate treatment of rheumatoid arthritis: effects on radiological progression. Scand J Rheumatol 18:221–226

    Article  CAS  PubMed  Google Scholar 

  42. Nordstrom DM, West SG, Andersen PA, Sharp JT (1987) Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study. Ann Intern Med 107:797–801

    Article  CAS  PubMed  Google Scholar 

  43. Rau R, Schleusser B, Herborn G, Karger T (1997) Longterm treatment of destructive rheumatoid arthritis with methotrexate. J Rheumatol 24:1881–1889

    CAS  PubMed  Google Scholar 

  44. Wassenberg S, Rau R (2002) Radiographic healing with sustained clinical remission in a patient with rheumatoid arthritis receiving methotrexate monotherapy. Arthritis Rheum 46:2804–2807

    Article  PubMed  Google Scholar 

  45. Nyfors A (1977) Liver biopsies from psoriatics related to methotrexate therapy. Acta Pathol Microbiol Scand A 85:511–518

    CAS  PubMed  Google Scholar 

  46. Dahl MGC, Gregory MM, Scheuer PJ (1972) Methotrexate hepatotoxicity in psoriasis – comparison of different dose regimes. Br Med J 1:654–656

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Rau R, Karger T, Herborn G, Frenzel H (1989) Liver biopsy findings in patients with rheumatoid arthritis under going longterm treatment with methotrexate. J Rheumatol 16:489–493

    CAS  PubMed  Google Scholar 

  48. Kremer JM (1992) Liver biopsies in patients with rheumatoid arthritis receiving methotrexate: where are we going? J Rheumatol 19:189–191

    CAS  PubMed  Google Scholar 

  49. Aponte J, Petrelli M (1988) Histopathologic findings in the liver of rheumatoid arthritis patients treated with longterm bolus methotrexate. Arthritis Rheum 31:1457–1464

    Article  CAS  PubMed  Google Scholar 

  50. Kremer JM, Phelps CT (1992) Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Arthritis Rheum 35:138–145

    Article  CAS  PubMed  Google Scholar 

  51. Rheumatoid Arthritis Clinical Trial Archive Group (1995) The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis. J Rheumatol 22:218–223

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Irisweg 5, 40489, Düsseldorf, Deutschland

    R. Rau

Authors
  1. R. Rau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Rau.

Ethics declarations

Interessenkonflikt

R. Rau gibt an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet frühere vom Autor durchgeführten Studien an Menschen oder Tieren.

Additional information

Redaktion

U. Müller-Ladner, Bad Nauheim

H.-M. Lorenz, Heidelberg

M. Schneider, Düsseldorf

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rau, R. Methotrexat. Z Rheumatol 75, 599–603 (2016). https://doi.org/10.1007/s00393-016-0118-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-016-0118-y

Search

Navigation